Compare Abbott Laboratories (ABT) vs J B Hunt Transport Services Inc (JBHT) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abbott Laboratories vs J B Hunt Transport Services Inc — how do they compare? Abbott Laboratories trades at $95.43 (market cap $166.94B), while J B Hunt Transport Services Inc trades at $273.91 (market cap $25.93B). The key difference: Abbott Laboratories is far larger — about 6.4× J B Hunt Transport Services Inc's market cap, and Abbott Laboratories pays the higher dividend (2.63%). Which is the better fit depends on your goals.
| ABT | JBHT | |
|---|---|---|
Market Cap | $166.94B | $25.93B |
Sector | Health | Industrials |
52-Week High | $136.62 | $290.07 |
52-Week Low | $82.57 | $130.65 |
Enterprise Value | $193.69B | $27.23B |
Dividend Yield | 2.63% | 0.65% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Abbott Laboratories (ABT) trades at $95.63, up 0.25% on the day, with a bullish technical signal from moving averages and strong analyst support. The stock shows solid fundamentals with a P/E of 26.79 and net income margin of 13.91%, though recent earnings have been mixed. Recent news highlights regulatory approvals for new medical devices, supporting growth prospects.
The outlook remains positive with a consensus price target of $122.55, implying significant upside. Key risks include competitive pressures and macroeconomic headwinds, but strong institutional backing and consistent dividend payments provide stability for long-term investors.
JBHT trades at $275.00, down 3.79% over 24 hours, with a bullish technical signal from moving averages and a neutral stance from oscillators. The company reported revenue of $12.00 billion in 2025 with a net income margin of 5.13%, and has beaten earnings estimates for the last three quarters. Recent news highlights its participation in industry conferences and positive analyst coverage amid a improving freight scenario.
The outlook for JBHT is supported by consistent earnings beats and a favorable analyst consensus, though high valuation ratios and exposure to freight market cyclicality present risks. Upside potential exists if the company maintains operational efficiency and capitalizes on industry tailwinds, but investors should weigh elevated P/E and P/B multiples against growth prospects.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Abbott Laboratories
Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, molecular diagnostic platforms, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
Read more on ABT →About J B Hunt Transport Services Inc
J.B. Hunt Transport Services ranks among the top surface transportation companies in North America by revenue. Its primary operating segments are intermodal delivery, which uses the Class I rail carriers for the underlying line-haul movement of its owned containers (45% of sales in 2021).
Read more on JBHT →
